Predicting Mucosal Proliferation in Ulcerative Colitis by Assessing Mucosal Vascular Pattern Under Narrow Band Imaging Colonoscopy.

BACKGROUND Proliferative abnormalities are believed to represent an early phase of colorectal carcinogenesis. Narrow band imaging (NBI) colonoscopy allows visual assessment of the mucosal vascular pattern (MVP) without dyeing. The aim of this study was to investigate the predictive value of MVP for mucosal proliferation in ulcerative colitis (UC). METHODS A total of 119 colorectal lesions were analyzed from 42 patients with UC who underwent NBI colonoscopy. Both the MVP and the Mayo endoscopic score (MES) were assessed. The mucosal inflammation was histologically graded using a colitis score. The proliferation marker Ki-67 was assessed by immunohistochemical staining. RESULTS The results showed that MVP correlated well with the MES (r = 0.796, P < .001). There was moderate correlation between the distribution of Ki-67 staining and MVP (r = 0.492, P < .001), and the Ki-67 labeling index increased with the orderly patterns of MVP (P < .001). An expansion of Ki-67 staining upward from the crypt base may be caused by active inflammation. CONCLUSION MVP based on NBI colonoscopy can predict mucosal proliferation which is associated with inflammation in patients with UC.

[1]  Weixun Zhou,et al.  Narrow-Band Imaging Colonoscopy to Assess Mucosal Angiogenesis in Ulcerative Colitis , 2019, Gastroenterology research and practice.

[2]  M. F. William A. Bye B. Com,et al.  Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis , 2018, The American Journal of Gastroenterology.

[3]  P. Rutgeerts,et al.  Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial , 2017, Gut.

[4]  Noor Mohammed,et al.  Clinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes? , 2016, World journal of gastroenterology.

[5]  L. Laine,et al.  Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis , 2016, The American Journal of Gastroenterology.

[6]  W. Sandborn,et al.  Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management , 2016, Cancer Prevention Research.

[7]  L. Roncucci,et al.  Inflammatory pathways in the early steps of colorectal cancer development. , 2014, World journal of gastroenterology.

[8]  P. Rutgeerts,et al.  Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[9]  O. Fratila,et al.  COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia. , 2013, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[10]  M. Esaki,et al.  ENDOSCOPIC FINDINGS UNDER NARROW BAND IMAGING COLONOSCOPY IN ULCERATIVE COLITIS , 2011, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[11]  M. Esaki,et al.  Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation , 2009, International Journal of Colorectal Disease.

[12]  J. Ellenberg,et al.  Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis , 2008, Inflammatory bowel diseases.

[13]  William M. Tierney,et al.  Narrow band imaging and multiband imaging. , 2008, Gastrointestinal endoscopy.

[14]  H. Nagawa,et al.  High proliferative activity is associated with dysplasia in ulcerative colitis , 2000, Diseases of the colon and rectum.

[15]  S. Mackell,et al.  Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis‐related dysplasia , 2000, Histopathology.

[16]  T. Rognum,et al.  Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. , 1998, Molecular pathology : MP.

[17]  C. Fenoglio-Preiser,et al.  The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis , 1996, Cancer.

[18]  J. Schölmerich,et al.  Expression of proliferating cell nuclear antigen (PCNA) and Ki‐67 in dysplasia in inflammatory bowel disease , 1996, European journal of gastroenterology & hepatology.

[19]  L. Barbara,et al.  Cell proliferation biomarkers in the gastrointestinal tract , 1992, Journal of cellular biochemistry. Supplement.

[20]  J. Gerdes,et al.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. , 1991, The American journal of pathology.